Notice: This company has been marked as potentially delisted and may not be actively trading. TenX Keane Acquisition (TENK) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOwnershipShort InterestTrends TENK vs. KALA, MRNS, UBX, DARE, VRCA, MTEX, CMMB, LIAN, CTXR, and LSBShould you be buying TenX Keane Acquisition stock or one of its competitors? The main competitors of TenX Keane Acquisition include KALA BIO (KALA), Marinus Pharmaceuticals (MRNS), Unity Biotechnology (UBX), Daré Bioscience (DARE), Verrica Pharmaceuticals (VRCA), Mannatech (MTEX), Chemomab Therapeutics (CMMB), LianBio (LIAN), Citius Pharmaceuticals (CTXR), and Lakeshore Biopharma (LSB). These companies are all part of the "pharmaceutical products" industry. TenX Keane Acquisition vs. KALA BIO Marinus Pharmaceuticals Unity Biotechnology Daré Bioscience Verrica Pharmaceuticals Mannatech Chemomab Therapeutics LianBio Citius Pharmaceuticals Lakeshore Biopharma KALA BIO (NASDAQ:KALA) and TenX Keane Acquisition (NASDAQ:TENK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Do insiders & institutionals believe in KALA or TENK? 24.6% of KALA BIO shares are held by institutional investors. Comparatively, 70.5% of TenX Keane Acquisition shares are held by institutional investors. 8.3% of KALA BIO shares are held by insiders. Comparatively, 22.9% of TenX Keane Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer KALA or TENK? KALA BIO received 300 more outperform votes than TenX Keane Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformKALA BIOOutperform Votes30066.82% Underperform Votes14933.18% TenX Keane AcquisitionN/AN/A Does the media favor KALA or TENK? In the previous week, KALA BIO had 3 more articles in the media than TenX Keane Acquisition. MarketBeat recorded 3 mentions for KALA BIO and 0 mentions for TenX Keane Acquisition. KALA BIO's average media sentiment score of 0.22 beat TenX Keane Acquisition's score of 0.00 indicating that KALA BIO is being referred to more favorably in the media. Company Overall Sentiment KALA BIO Neutral TenX Keane Acquisition Neutral Do analysts recommend KALA or TENK? KALA BIO presently has a consensus price target of $15.00, suggesting a potential upside of 125.56%. Given KALA BIO's stronger consensus rating and higher possible upside, research analysts clearly believe KALA BIO is more favorable than TenX Keane Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KALA BIO 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00TenX Keane Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is KALA or TENK more profitable? TenX Keane Acquisition's return on equity of 0.00% beat KALA BIO's return on equity.Company Net Margins Return on Equity Return on Assets KALA BION/A -448.61% -69.37% TenX Keane Acquisition N/A N/A N/A Which has preferable earnings & valuation, KALA or TENK? TenX Keane Acquisition has lower revenue, but higher earnings than KALA BIO. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKALA BIO$3.89M7.88-$42.20M-$12.47-0.53TenX Keane AcquisitionN/AN/AN/AN/AN/A SummaryKALA BIO beats TenX Keane Acquisition on 7 of the 11 factors compared between the two stocks. Get TenX Keane Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TENK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENK vs. The Competition Export to ExcelMetricTenX Keane AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$7.05M$441.64M$119.13M$8.80BDividend YieldN/A7.23%5.15%4.00%P/E RatioN/A2.541.2516.96Price / SalesN/A105.231.64123.65Price / CashN/A64.1285.1337.77Price / BookN/A84.20519.854.89Net IncomeN/A$34.94M$1.86M$228.40M TenX Keane Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENKTenX Keane AcquisitionN/A$1.06-3.6%N/A-90.0%$7.05MN/A0.00N/AKALAKALA BIO4.3167 of 5 stars$6.55-3.8%$15.00+129.0%-17.4%$30.20M$3.89M-0.5330Short Interest ↑MRNSMarinus Pharmaceuticals4.5943 of 5 stars$0.54+0.8%$4.79+784.4%-94.5%$29.88M$31.47M-0.22110Analyst ForecastShort Interest ↓UBXUnity Biotechnology4.1432 of 5 stars$1.72-3.9%$7.33+326.4%-8.1%$28.98M$240,000.00-1.3160DAREDaré Bioscience1.5018 of 5 stars$3.33+6.7%$24.00+620.7%-23.5%$28.97M$1.88M-5.6430Short Interest ↑VRCAVerrica Pharmaceuticals4.4364 of 5 stars$0.64-3.8%$9.50+1,396.1%-88.5%$28.96M$9.21M-0.3540Positive NewsGap UpMTEXMannatech0.6332 of 5 stars$15.17+1.3%N/A+44.6%$28.60M$121.55M-18.73250Analyst ForecastShort Interest ↑News CoverageCMMBChemomab Therapeutics3.8675 of 5 stars$1.98-6.6%$7.50+278.8%+239.9%$28.43MN/A-1.9820Short Interest ↓Positive NewsLIANLianBioN/A$0.26+1.2%N/A-93.7%$28.43MN/A-0.32110CTXRCitius Pharmaceuticals2.7038 of 5 stars$3.49-3.9%$54.50+1,461.6%-81.0%$26.97MN/A-0.5820Short Interest ↑LSBLakeshore Biopharma1.1299 of 5 stars$2.86-7.1%N/AN/A$26.62M$672.27M0.00773Short Interest ↓ Related Companies and Tools Related Companies KALA Alternatives MRNS Alternatives UBX Alternatives DARE Alternatives VRCA Alternatives MTEX Alternatives CMMB Alternatives LIAN Alternatives CTXR Alternatives LSB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TENK) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TenX Keane Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Share TenX Keane Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TENK Stock Alerts